Home & Garden Pet Products Pet Health Care & Supplements

60ul Sample Troponin I Rapid Test Kit

Price Negotiable
Price: To be negotiated
MOQ: To be negotiated
Delivery Time: To be negotiated
Brand: Combined detection reagent of troponin I, myoglobin and creatine kinase isoenzyme(cTnl/MYO/CK-MB)
Product Description

Combined Detection Reagent Of Troponin I,Myoglobin And Creatine Kinase Isoenzyme(CTnl/MYO/CK-MB)

 

CTnI/MYO/CK-MB Overview


Cardiac troponin I/myoglobin/creatine kinase isoenzyme (cTnI/myo/CK-MB) includes the detection of the following three indicators: cardiac troponin I (cTnI), myoglobin (myo), creatine kinase isoenzyme (CK-MB). The combined detection of these three indicators is of great significance in the early diagnosis of acute myocardial diseases such as acute myocardial infarction (AMI).

 

American Academy of Clinical Biochemical Sciences (Nacb) practice guide

Myocardial necrosis markers should be detected in all suspected ACS patients
Troponin is the first choice for the diagnosis of myocardial infarction
Myoglobin combined with specific markers of myocardial necrosis (such as cTnI/CK-MB) is helpful to more quickly exclude or diagnose myocardial infarction

 

 

  MYO CK-MB cTnI
molecular weight 17.8KD 86KD 22.5KD
Rise time 1-2h 4-6h 3-6h
Peak time 6-9h 24h 12-16h
recovery time 18-30h 2-3d 4-10d
Clinical value 1. The most important index of AMI early exclusion
2. The best index of AMI recurrence diagnosis and reperfusion treatment effect evaluation
1. Estimate infarct size or reinfarction
2. The most valuable marker of non ST segment elevation MI
1. The first choice marker for AMI diagnosis
2. Determine the infarct size and make risk stratification

 

 

CTnI/MYO/CK-MB Clinical Significance


  • It is helpful for early diagnosis and risk stratification of acute coronary syndrome
  • The area of myocardial ischemia injury was determined
  • Differential diagnosis of various causes of chest pain
  • Monitoring of myocardial injury caused by various causes
  • Clinical evaluation of some therapeutic drugs

 

Possibility of outcome  
cTnI CK-MB MYO Clinical possibility

+

+ + Myocardial infarction / myocardial injury can be diagnosed basically, and the occurrence time is within 12-24 hours;
+ + - Basically, it can be diagnosed as myocardial infarction / myocardial injury, and the detection time is more than 1 day, which has passed the detection window period of myo;
+ - - Myocardial infarction / myocardial injury has occurred for 2-3 days, it is recommended to reexamine after a few hours;
+ - + In patients with myocardial infarction / myocardial injury, the detection time may be more than 3 days, and the patients may have re injury or enlarged infarct size;
- + + For early myocardial infarction / myocardial injury / muscle injury, cTnI should be reexamined within 4-8 hours;

-

- + 1. Early myocardial infarction / myocardial injury, cTnI should be reexamined within 4-8 hours;
2. It may be caused by other injury diseases, such as creation, skeletal muscle injury, liver and kidney disease;
- + - 1. Minor myocardial injury, cTnI should be reexamined within 4-8 hours;
2. It may be a non myocardial injury disease, and the detection time has passed the myo window;

-

- - Myocardial infarction / myocardial injury is basically ruled out. If it is highly suspected, reexamination is recommended every 2-4 hours.

 

 

cTnI/MYO/CK-MB Performance Index


Detection range sample size Sample type Test time
cTnI MYO CK-MB 60μl Whole blood / serum / plasma 15min
0.1~50ng/mL 10~200ng/mL 0.8~100ng/mL

 

 

 

Application Department


Outpatient, emergency, physical examination center, cardiovascular, ICU, chest pain center and other departments

 

 

CTnI/MYO/CK-MB Clinical Comparison


 

 

Company profile


ZOS-F2100(Multi-Channel) 4ZOS-F2100(Multi-Channel) 5ZOS-F2100(Multi-Channel) 6ZOS-F2100(Multi-Channel) 7

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

 

 

 

 

Get in Touch

Have questions about our products or want to discuss a custom order? Our team is ready to help you.

Company Henan Lantian Medical Supplies Co.,Ltd.
Location Office Address: Building 4, No. 51 Jingbei 3rd Road, Jingkai Zone, Zhengzhou City. Henan Province,China.
Contact Person chen

Request A Quote

Please check your email address.
Your message must be at least 20 characters.